Trioxifene is a selective estrogen receptor modulator used in the treatment of metastatic breast cancer in men and women, functioning by blocking estrogen receptors to inhibit tumor growth. This category… Read more
Trioxifene is a selective estrogen receptor modulator used in the treatment of metastatic breast cancer in men and women, functioning by blocking estrogen receptors to inhibit tumor growth. This category includes high-quality reference standards for the Trioxifene active pharmaceutical ingredient, along with a selection of related impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical and analytical laboratories rely on these specialized compounds for critical applications such as impurity profiling, method development, and rigorous quality control testing. By utilizing these materials, researchers can ensure accurate identification and quantification of the parent drug and its degradation products throughout the analytical lifecycle. These compounds are essential tools for maintaining regulatory compliance and upholding the safety and efficacy standards required in modern pharmaceutical analysis.